1 | | (2S,3S)- | (2S,3S)- | C24H27ClN2O6S
| Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals | |
2 | 1890114-11-0 | (2S,2'S)-[[(2R, 5R)-1-[3,5-二氟-4-(4-(4-氟苯基)哌啶-1-基)苯胺]-2,5-双四氢吡咯基]双[6-氟-2-(2S)-2-四氢吡咯-1H-苯并咪唑-2,5-二基)]双(1-四氢吡咯甲酸叔丁酯) | (2s,2's)- | C53H59F5N8O4
| | |
3 | 96314-29-3 | N-叔丁氧羰基-(2S,4S)-4-苯基吡咯烷-2-羧酸 | (2S,4S)-4 | C16H21NO4
| 氨基酸衍生化合物 | |
4 | 67174-25-8 | N-苄基奎宁氯 | (2S,4S,5R) | C27H31ClN2O2
| 手性砌块;不对称合成 | |
5 | | 青霉素V-D5 | (2S,5R,6R) | C16H18N2O5S
| 同位素标记物;青霉素类;Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Heterocycles;Isotope Labelled Compounds;Sulfur & Selenium Compounds | |
6 | 61478-29-3 | (2S,4S)-4-二苯基膦-2-(二苯基膦甲基)-吡咯烷 | (2S,4S)-PPM | C29H29NP2
| 膦配体;有机配体 | |
7 | 1424832-57-4 | (2S,3S)-E1R | (2S,3S)-E1R | C13H16N2O2
| | |
8 | 1808948-28-8 | 化合物 T26371 | (2S,3R)-LP99 | C26H30ClN3O4S
| | |
9 | 1093625-96-7 | (2S,3R,6R,S)-2 - (3 - 氧代丁基)-3 - 甲基-6 - [(R) - 2 - 丙醛]环己酮 | (2S,3R,6RS)- | C14 H22 O3
| 化工原料 | |
10 | 62023-62-5 | (2S,3S)-3-氨基-2-羟基-4-苯丁酸 | (2S,3S)-AHPA | C10H13NO3
| 有机化工原料 | |
11 | 128223-55-2 | (2S,3R)-3-氨基-2-羟基-4-苯基丁酸盐酸盐 | (2S,3R)-AHPA | C10H14ClNO3
| | |
12 | 7361-76-4 | (+)-PENTAZOCINE - DEA SCHEDULE IV ITEM | (2S,6S,11S)- | C19H27NO
| | |
13 | 7240-38-2 | 苯唑青霉素钠 | (2S,5R,6R)-3, | C19H18N3NaO5S
| | |
14 | 22900-11-4 | N-乙酰神经氨酸甲酯 | (2S,4S,5R,6R) | C12H21NO9
| 单糖;基准试剂 | 单糖;基准试剂;Carbohydrates & Derivatives;Biochemistry;Sialic Acids;Sugars |
15 | 3080-29-3 | L-腺苷 | (2S,3S,4R,5S) | C10H13N5O4
| 其他 | |
16 | 1223-07-0 | 4-硝基苯基α-L-吡喃阿拉伯糖苷 | (2S,3R,4S,5S) | C11H13NO7
| 酶底物;糖类化合物;植物提取物;通用生化试剂-糖类;生化试剂-碳水化合物类 | |
17 | 87333-19-5 | 雷米普利 | (2S,3aS,6aS)- | C23H32N2O5
| 药物;原料;中间体;原料药;医药原料;药物原料;抗生素类;有机原料;医用原料;降压降糖类 | 医药;成品药 |
18 | 241811-65-4 | (2S 3S 5S 6S)-5 6-DIMETHOXY-5 6-DIMETHY& | (2S,3S,5S,6S) | C12H20O8
| | |
19 | | (6S,7S)-5,6,7,8-Tetrahydro-6α-methyl-7β-dipropylaminonaphthalen-1-ol | (2S,3S)-CM-12 |
| | |
20 | 117857-96-2 | L-CCG-IV | (2S,3R,4S)-CCG | C6H9NO4
| | |
21 | 1215081-28-9 | [(2S,3R)-2-[二叔丁基膦]-3-叔丁基-2,3-二氢-4-甲氧基-1,3-苯并氧磷杂环戊二烯] | (2S,3R)-MeO-POP | C20H34O2P2
| | |
22 | 146142-94-1 | (2S,4S)-2-氨基-4-羧基-4-羟基-5-(3-吲哚基)戊酸 | (2S,4S)-monatin | C14H16N2O5
| | |
23 | 54081-47-9 | 新落新妇苷 | (2S,3S)-Astilbin | C21H22O11
| 对照品;标准品,对照品 | |
24 | 54141-72-9 | 新异落新妇苷 | (2S,3R)-Astilbin | C21H22O11
| 对照品;标准品,对照品 | |
25 | 1373432-11-1 | (2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-甲基-2,3-二氢苯并[D][1,3]氧,膦戊轭 | (2S,3S)-Me-BIDIME | C20H25O3P
| 膦配体;有机配体 | |
26 | 185244-78-4 | 肥牛木素 | (2S,3R)-Ceplignan | C18H18O7
| | |
27 | 62023-62-5 | (2S,3S)-3-氨基-2-羟基-4-苯丁酸 | (2S,3S)-H-APNS-OH | C10H13NO3
| 有机化工原料 | |
28 | 62023-59-0 | (2S,3S)-3-苄氧羰酰氨基-2-羟基-4-苯丁酸, | (2S,3S)-H-APNS-OH | C18H19NO5
| | |
29 | | (2S,3R)-CHLORPHEG | (2S,3R)-CHLORPHEG |
| | |
30 | 110764-35-7 | (2S,3'Z)-Cefprozil | (2S,3'Z)-Cefprozil | C18H19N3O5S
| | |
31 | 1477517-21-7 | (2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-异丙基-2,3-二氢苯并[d] [1,3]氧磷杂环庚三烯 | (2S,3S)-iPr-BIDIME | C22H29O3P
| 膦配体;有机配体 | |
32 | 112741-50-1 | (2S,3R)-N-叔丁氧羰基-2,3-二苯基吗啉-6-酮 | (2S,3R)-tert-Butyl | C21H23NO4
| 氨基酸;医药中间体 | |
33 | 149709-63-7 | LCZ 696杂质C | (2S,4S)-Sacubitril | C24H29NO5
| 杂质对照品;对照品-标准品 | |
34 | 1243259-19-9 | (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide Hydrochloride | (2S,3S)-2-AMINO-3- | C12H26ClN3O2
| 定制 | |
35 | 35938-43-3 | 蕨素C | (2S,3S)-pterosin C | C14H18O3
| 标准品;倍半萜;中药对照品;分析试剂标准品 | |
36 | 1253731-24-6 | 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one | (2S,3R)-Voruciclib | C22H19ClF3NO5
| | |
37 | 189264-03-7 | (2S,4S)-阿加曲班 | (2S,4S)-Argatroban | C23H36N6O5S
| 杂质世界;杂质对照品;065-阿加曲班;对照品-杂质对照品 | |
38 | | (2S,3S)-N-BOC-FORM | (2S,3S)-N-BOC-FORM |
| | |
39 | | (2S,3S)-CBZ-N-FORM | (2S,3S)-CBZ-N-FORM |
| | |
40 | 33511-69-2 | (2s,3R)-3-Methylglutamic acid | (2s,3R)-3-Me-Glu-OH | C6H11NO4
| | |
41 | 33511-70-5 | (2s,3s)-3-Methylglutamic acid | (2s,3s)-3-Me-Glu-OH | C6H11NO4
| | |
42 | 32946-42-2 | erythro-L-Phenylserine | (2S,3S)-Phenyserine | C9H11NO3
| 氨基酸 | |
43 | 922-56-5 | (2S,6R)-羊毛硫氨酸 | (2S,6R)-Lanthionine | C6H12N2O4S
| | |
44 | 98855-62-0 | (2S,3S)-Pteroside C | (2S,3S)-Pteroside C | C20H28O8
| | |
45 | 144540-75-0 | (2S,3aR,7aS)-1H-八氢吲哚-2-羧酸盐酸盐 | (2S,3aR,7aS)-1H-Octa | C9H16ClNO2
| 群多普利中间体 | |
46 | | (2S,5R,S)-2-ETHYL-1,6-DIOXASPIRO[4.4]NONANE | (2S,5R,S)-CHALCOGRAN | C9H16O2
| | |
47 | | (2S)-2β-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-4α-[4-(4-acetylpiperazino)phenoxymethyl]-1,3-dioxolane | (2S,4R)-Ketoconazole |
| | |
48 | 72-19-5 | L-苏氨酸 | (2S,3R)-(-)-Threonine | C4H9NO3
| 氨基酸;标准品;对照品;原料药;氨酸类;生化试剂;氨基酸类;有机原料;兽药原料;中性氨基酸 | 医药 |
49 | 1202033-17-7 | (2S,2'S,3S,3'S)-BIBOP | (2S,2'S,3S,3'S)-BIBOP | C22H28O2P2
| | |
50 | 911415-22-0 | 1,1'-[((1S,3S)-1,3-二甲基-1,3-丙二基]双[1,1-双[4-(1,1-二甲基乙基)苯基]-膦 | (2S,4S)-PTBP-Skewphos | C45H62P2
| | |